Western Alliance Bancorp (WABC34Q) News

Evofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1st

SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) -- Women’s health innovator Evofem Biosciences, Inc. (“Evofem” or...

Aditxt Signs Second Amendment to the Arrangement Agreement with Appili Therapeutics, Targeting September 30 Closing of the Acquisition

Appili, with a commercial-stage pipeline, has raised CAD $100M towards developing therapeutics for the global infectious disease and biodefense...

Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1

Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1 PR Newswire SAN DIEGO, July 23, 2024 —...

Form 8-K - Current report

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Aditxt and Evofem Amend and Restate Merger Agreement, Targeting September 30 Closing

Evofem Acquires SOLOSEC, an FDA-Approved Single-Dose Treatment for Bacterial Vaginosis and Trichomoniasis Aditxt, Inc. (“Aditxt”) (NASDAQ: ADTX...

Form S-3 - Registration statement under Securities Act of 1933

Form 8-K - Current report

Form 8-K - Current report

Hello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women's Healthcare

Hello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

Form PRER14A - Preliminary Proxy Soliciting materials